William Blair Maintains Century Therapeutics(IPSC.US) With Hold Rating

Futu NewsJan 14 20:36 · Ratings

Cautious Optimism on Century Therapeutics: Promising Early-Stage Developments But Awaiting Further Data

TipRanksJan 14 20:08

Century Therapeutics Unveils Advances in Cell Therapies

TipRanksJan 13 21:00

Century Therapeutics Is Maintained at Overweight by Piper Sandler

Dow JonesDec 31, 2024 01:29 · Ratings

Century Therapeutics Analyst Ratings

BenzingaDec 31, 2024 01:15 · Ratings

Piper Sandler Maintains Century Therapeutics(IPSC.US) With Buy Rating, Cuts Target Price to $4

Futu NewsDec 30, 2024 19:31 · Ratings